Background illustration for clinical trials search

Paid Clinical Trials Detroit

Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,705

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for

Core Binding Factor Acute Myeloid Leukemia

Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase2, Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

for

Castration-Resistant Prostate Carcinoma,

Location: Livonia MI, Canton MI, Ypsilanti MI, Brighton MI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06632977

Phase2, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Livonia MI, Canton MI, Pontiac MI, Ann Arbor MI,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase2, Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06317649

Phase2, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase2, Phase3, Recruiting

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

for

Colorectal Cancer, Sarcopenia

Location: Livonia MI, Canton MI, Pontiac MI, Ann Arbor MI,

Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 60+

Code: NCT03998202

Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for

Metastatic Head and Neck Squamous Cell Carcinoma,

Location: Livonia MI, Canton MI, Pontiac MI, Ann Arbor MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase3, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for

Malignant Female Reproductive System Neoplasm,

Location: Livonia MI, Canton MI, Pontiac MI, Ann Arbor MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),

Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

New

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

for

Type 2 Diabetes, Cardiovascular Risk

Location: Troy MI, Flint MI, Maumee OH, Hazel Crest IL, Gurnee IL,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 45+

Code: NCT07797335

Phase3, Recruiting

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

for

Obesity, Overweight

Location: Troy MI, London, Guelph, Hamilton, Toronto, Stouffville,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT07662122

Phase2, Recruiting

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

for

Lipoprotein(a)

Location: Troy MI, Columbus OH, Manassas VA, Rockville MD,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07614984

Phase2, Recruiting

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

for

Type 2 Diabetes

Location: Troy MI, Maumee OH, Canton OH, Burke VA, Midlothian VA,

Sponsor: Housey Healthcare ULC

Sex: All

Age: 18+

Code: NCT07546929

Phase2, Recruiting

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

for

Peripheral Arterial Disease

Location: Troy MI, Stoney Creek, Toronto, Hammond IN,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07223593

Phase3, Recruiting

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

for

Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia

Location: Sterling Heights MI, Dublin OH, Toronto, Cincinnati OH,

Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 65

Code: NCT07096674

Phase2, Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for

Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia

Location: Sterling Heights MI, Lansing MI, Canton OH, Dublin OH,

Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase2, Phase3, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for

Graves' Disease

Location: Farmington Hills MI, Flint MI, Canton OH,

Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase2, Recruiting

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

for

Acute Ischemic Stroke

Location: Mount Clemens MI, Toledo OH, Flint MI, Lansing MI,

Sponsor: Mercy Health Ohio

Sex: All

Age: 18 - 70+

Code: NCT05611242

Phase3, Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for

Relapsing Multiple Sclerosis

Location: Farmington MI, Cleveland OH, Dayton OH, Indianapolis IN,

Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase3, Recruiting

Paid Clinical Trials Detroit

Filter results

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Interested in new trials?

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab